tiprankstipranks
Trending News
More News >
RedHill Biopharma (RDHL)
NASDAQ:RDHL
US Market

RedHill Biopharma (RDHL) Income Statement

Compare
868 Followers

RedHill Biopharma Income Statement

Last quarter (Q2 2025), RedHill Biopharma's total revenue was $2.04M, an increase of 58.59% from the same quarter last year. In Q2, RedHill Biopharma's net income was $-2.07M. See RedHill Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 8.04M$ 6.53M$ 61.80M$ 85.76M$ 64.36M
Gross Profit
$ 4.85M$ 3.07M$ 28.46M$ 36.35M$ 27.47M
Operating Expenses
$ 19.46M$ -9.56M$ 71.31M$ 117.49M$ 91.15M
Depreciation and Amortization
$ 619.00K$ 1.99M$ 8.15M$ 18.15M$ 8.74M
EBITDA
$ -7.59M$ 26.27M$ -22.18M$ -63.03M$ -54.98M
Operating Income
$ -14.61M$ 12.63M$ -42.84M$ -81.14M$ -63.68M
Other Income/Expenses
$ 6.34M$ 11.28M$ -28.82M$ -16.61M$ -12.49M
Pretax Income
$ -8.27M$ 23.92M$ -71.67M$ -97.74M$ -76.17M
Net Income
$ -8.27M$ 23.92M$ -71.67M$ -97.74M$ -76.17M
Per Share Metrics
Basic EPS
$ -7.00$ 46.00$ -600.00$ -1.00K$ -1.00K
Diluted EPS
$ -7.00$ 46.00$ -600.00$ -1.00K$ -1.00K
Weighted Average Shares Outstanding
2.46M 518.24K 123.86K 93.05K 72.85K
Weighted Average Shares Outstanding (Diluted)
2.46M 518.24K 123.86K 93.05K 72.85K
Currency in USD

RedHill Biopharma Earnings and Revenue History